Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0060
-0.0005
(-7.69%)
As of 5:00:02 PM GMT+1. Market Open.
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Cash Flow
-8,294
-8,294
-5,177
-5,918
-3,401
Investing Cash Flow
-620
-620
1,251
2,827
4,580
Financing Cash Flow
13,207
13,207
2,562
-804
-181
End Cash Position
5,250
5,250
974
2,175
6,119
Capital Expenditure
-716
-716
-901
-3,089
-457
Issuance of Capital Stock
15,387
15,387
3,623
--
--
Free Cash Flow
-9,010
-9,010
-6,078
-9,007
-3,858
9/30/2020 - 1/19/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INTS Intensity Therapeutics, Inc.
2.3000
-1.68%
WXXWY WuXi Biologics (Cayman) Inc.
5.65
-0.88%
PTGX Protagonist Therapeutics, Inc.
38.39
+2.11%
NNVC NanoViricides, Inc.
1.2000
-9.09%
ROIV Roivant Sciences Ltd.
10.25
-4.56%
TNXP Tonix Pharmaceuticals Holding Corp.
7.44
-5.34%
ENVB Enveric Biosciences, Inc.
2.7300
-2.50%
NVAX Novavax, Inc.
7.91
-5.10%